Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Balancing testosterone may reduce COVID-19 severity.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Natural plant compounds may offer safer COVID-19 treatments with fewer side effects.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Syphilis can cause hair loss that looks like other conditions, but it improves with treatment.

Using platelet-rich plasma with primary repair improves healing in penile fractures.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

COVID-19 may worsen with androgens; anti-androgen drugs could help.